Found: 17
Select item for more details and to access through your institution.
LYN kinase programs stromal fibroblasts to facilitate leukemic survival via regulation of c-JUN and THBS1.
- Published in:
- Nature Communications, 2023, n. 1, p. 1, doi. 10.1038/s41467-023-36824-2
- By:
- Publication type:
- Article
Publisher Correction: Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myeloma.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myeloma.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-33142-x
- By:
- Publication type:
- Article
Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myeloma.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-33142-x
- By:
- Publication type:
- Article
Comparative proteomics reveals a diagnostic signature for pulmonary head‐and‐neck cancer metastasis.
- Published in:
- EMBO Molecular Medicine, 2018, v. 10, n. 9, p. 1, doi. 10.15252/emmm.201708428
- By:
- Publication type:
- Article
Combining affinity enrichment, cross-linking with photo amino acids, and mass spectrometry for probing protein kinase D2 interactions.
- Published in:
- Proteomics, 2017, v. 17, n. 10, p. n/a, doi. 10.1002/pmic.201600459
- By:
- Publication type:
- Article
The MYC-Regulated RNA-Binding Proteins hnRNPC and LARP1 Are Drivers of Multiple Myeloma Cell Growth and Disease Progression and Negatively Predict Patient Survival.
- Published in:
- Cancers, 2023, v. 15, n. 23, p. 5508, doi. 10.3390/cancers15235508
- By:
- Publication type:
- Article
The RHOA Mutation G17V Does Not Lead to Increased Migration of Human Malignant T Cells but Is Associated with Matrix Remodelling.
- Published in:
- Cancers, 2023, v. 15, n. 12, p. 3226, doi. 10.3390/cancers15123226
- By:
- Publication type:
- Article
Metabolic Plasticity Is an Essential Requirement of Acquired Tyrosine Kinase Inhibitor Resistance in Chronic Myeloid Leukemia.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3443, doi. 10.3390/cancers12113443
- By:
- Publication type:
- Article
T-cell-derived Hodgkin lymphoma has motility characteristics intermediate between Hodgkin and anaplastic large cell lymphoma.
- Published in:
- Journal of Cellular & Molecular Medicine, 2022, v. 26, n. 12, p. 3495, doi. 10.1111/jcmm.17389
- By:
- Publication type:
- Article
Correction: The non-apoptotic function of Caspase-8 in negatively regulating the CDK9-mediated Ser2 phosphorylation of RNA polymerase II in cervical cancer.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
The non-apoptotic function of Caspase-8 in negatively regulating the CDK9-mediated Ser2 phosphorylation of RNA polymerase II in cervical cancer.
- Published in:
- Cellular & Molecular Life Sciences, 2022, v. 79, n. 12, p. 1, doi. 10.1007/s00018-022-04598-3
- By:
- Publication type:
- Article
The transcription factor TAL1 and miR-17-92 create a regulatory loop in hematopoiesis.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-78629-z
- By:
- Publication type:
- Article
Activation of CD44/PAK1/AKT signaling promotes resistance to FGFR1 inhibition in squamous-cell lung cancer.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-022-00296-2
- By:
- Publication type:
- Article
Identification of the Cysteine Protease Legumain as a Potential Chronic Hypoxia-Specific Multiple Myeloma Target Gene.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 2, p. 292, doi. 10.3390/cells11020292
- By:
- Publication type:
- Article
Integrated analysis of relapsed B-cell precursor Acute Lymphoblastic Leukemia identifies subtype-specific cytokine and metabolic signatures.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-019-40786-1
- By:
- Publication type:
- Article
PRMT6 activates cyclin D1 expression in conjunction with the transcription factor LEF1.
- Published in:
- Oncogenesis, 2021, v. 10, n. 5, p. 1, doi. 10.1038/s41389-021-00332-z
- By:
- Publication type:
- Article